DIPHENYL SULFIDE DERIVATIVE AND PHARMACEUTICAL PRODUCT WHICH CONTAINS SAME AS ACTIVE INGREDIENT
申请人:Ishikawa Kumi
公开号:US20130261089A1
公开(公告)日:2013-10-03
[Problem] To provide a diphenyl sulfide derivative which is useful as a pharmaceutical product that has excellent S1P3 antagonist activity.
[Solution] The inventors have discovered that a diphenyl sulfide derivative represented by general formula (1) (wherein R1 represents an alkoxy group having 1-6 carbon atoms, R2 represents a propyl group or an allyl group, X represents methylene or an oxygen atom, and Z represents a halogen atom) has excellent S1P3 antagonist activity as a result of extensive researches for the production of a compound that has S1P3 antagonist activity.
Diphenyl sulfide derivatives and medicines containing same as active ingredient
申请人:Kohno Yasushi
公开号:US08569270B2
公开(公告)日:2013-10-29
Provided are diphenyl sulfide derivatives which have excellent S1P3 antagonistic activity and are useful as drugs. Intensive studies have been made for the purpose of creating a compound having S1P3 antagonistic activity. As a result of the intensive studies, it has been found that diphenyl sulfide derivatives represented by general formula (1) have excellent S1P3 antagonistic activity. In general formula (1), R1 is a hydrogen atom or the like; R2 is an optionally substituted alkyl group having 1 to 6 carbon atoms, or the like; X is a methylene group which may be substituted with one or two fluorine atoms, or the like; Y is a hydrogen atom or the like; and Z is a halogen atom.
Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
申请人:Ishikawa Kumi
公开号:US08993543B2
公开(公告)日:2015-03-31
[Problem] To provide a diphenyl sulfide derivative which is useful as a pharmaceutical product that has excellent S1P3 antagonist activity.
[Solution] The inventors have discovered that a diphenyl sulfide derivative represented by general formula (1) (wherein R1 represents an alkoxy group having 1-6 carbon atoms, R2 represents a propyl group or an allyl group, X represents methylene or an oxygen atom, and Z represents a halogen atom) has excellent S1P3 antagonist activity as a result of extensive researches for the production of a compound that has S1P3 antagonist activity.
Compounds of formula (I) wherein the substituents have the meanings assigned to them in claim
1,
are useful as pesticides.
式(I)中的化合物,其中取代基具有在权利要求书1中分配给它们的含义,可用作杀虫剂。
Investigation of the monoamine oxidase inhibition properties of benzoxathiolone derivatives
作者:Izak F. Prinsloo、Anél Petzer、Theunis T. Cloete、Jacobus P. Petzer
DOI:10.1007/s00044-023-03042-w
日期:——
specificity for the MAO-B isoform. To expand on these findings, the present study synthesised series of benzoxathiolone derivatives and investigated their human MAO inhibitionproperties. The results showed that the benzoxathiolone derivatives were potent MAO inhibitors, with the most potent compounds exhibiting IC50 values of 0.083 and 0.086 µM (4d and 5e) and 0.0069 and 0.0066 µM (3a and 3b) for MAO-A and
神经精神疾病和神经退行性疾病(如抑郁症和帕金森病)的治疗是医疗保健领域的重大挑战。代谢神经递质胺的酶是这些疾病的重要药物靶标,这些酶的抑制剂作为治疗剂发挥了关键作用。例如,单胺氧化酶 (MAO) A 抑制剂几十年来一直用作抗抑郁药,通过抑制血清素和去甲肾上腺素的中枢代谢发挥作用,而 MAO-B 抑制剂可保护中枢多巴胺供应并已用于治疗帕金森病。文献报道,苯并恶硫酮衍生物可作为有效的 MAO 抑制剂,对 MAO-B 亚型具有特异性。为了扩展这些发现,本研究合成了一系列苯并恶硫酮衍生物并研究了它们对人类 MAO 的抑制特性。结果表明,苯并恶硫酮衍生物是有效的 MAO 抑制剂,其中最有效的化合物表现出 ICMAO-A 和 MAO-B 的50 个值分别为 0.083 和 0.086 µM(4d和5e)以及 0.0069 和 0.0066 µM(3a和3b)。与之前报道的化合物相比,化合物4d和5e是显着更有效的